Cargando…
Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
Low-density lipoprotein receptor (LDLR) is a key regulator of the metabolism of plasma low-density lipoprotein cholesterol (LDL-C), the elevated levels of which are associated with an increased risk of cardiovascular disease. Therefore, enhancing LDLR expression represents a potent treatment strateg...
Autores principales: | Bjune, Katrine, Wierød, Lene, Naderi, Soheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212527/ https://www.ncbi.nlm.nih.gov/pubmed/30385871 http://dx.doi.org/10.1038/s41598-018-34237-6 |
Ejemplares similares
-
Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms
por: Bjune, Katrine, et al.
Publicado: (2019) -
Triciribine Engages ZFP36L1 and HuR to Stabilize LDLR mRNA
por: Sundvold, Hilde
Publicado: (2020) -
Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells
por: Choi, Yu-Jeong, et al.
Publicado: (2020) -
LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis
por: Shi, Xiangguang, et al.
Publicado: (2022) -
Control of LDL Uptake in Human Cells by Targeting the LDLR Regulatory Long Non-coding RNA BM450697
por: Ray, Roslyn M., et al.
Publicado: (2019)